Grossi Federico
CIK 0001720634
Chief Medical Officer
Filings
16
Latest Jan 7, 2025
Issuers covered
2
Showing
16 of 16
Page 1
Track record
9 of 9 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 33% | -7.2% | -9.9% | +17.0% | -31.9% |
| 90 days | 9 | 33% | -18.1% | -19.6% | +17.5% | -62.6% |
| 180 days | 9 | 11% | -37.8% | -34.5% | +1.6% | -85.6% |
| 365 days | 9 | 0% | -45.2% | -34.3% | -3.1% | -111.1% |
Issuers
Companies where Grossi Federico has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 15 | Jan 9, 2023 |
| UBX | Unity Biotechnology, Inc. | 1 | Jan 7, 2025 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|